IRadimed Corporation (IRMD) Stock Score, Valuation & Financial Research
IRadimed Corporation is in the Healthcare sector and Medical - Devices industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 47/100.
Quick answer for IRMD
IRadimed Corporation currently has a Wall Street Score of 47/100. The stored market price is $82.58. Its financial score is 42/100. Its valuation score is 4/100. The latest WSS change is +0.5 points. These figures are a research snapshot, not a buy or sell recommendation.
What IRadimed Corporation does
IRADIMED CORPORATION specializes in the engineering, production, and distribution of medical devices specifically designed for compatibility with magnetic resonance imaging (MRI) environments. The company supplies these specialized products, alongside their related accessories and support services, to both U.S. and international markets. Key offerings include the MRidium MRI-compatible intravenous (IV) infusion pump system, which comes with disposable tubing sets, and an MRI-compatible patient vital signs monitoring system. Furthermore, IRADIMED provides a range of complementary items such as non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring solutions with sensors. Their clientele primarily consists of hospitals, acute care facilities, and outpatient imaging centers. Sales are conducted via direct field repr
IRMD financial snapshot
- Wall Street Score:
- 47/100
- Current price:
- $82.58
- Market capitalization:
- $1.06B
- Revenue:
- $86.3M
- Net income:
- $23.1M
- Free cash flow:
- $17.2M
- Cash:
- $59.1M
- Total debt:
- $0
- EPS:
- 1.77
- P/E ratio:
- 46.7x
- Financial score:
- 42/100
- Valuation score:
- 4/100
- Revenue score:
- 27/100
What stands out
- Reported year-over-year revenue growth is +0.0%.
- Free cash flow is $17.2M, showing positive cash generation.
- The balance sheet shows $59.1M of cash versus $0 of total debt, leaving more cash than debt.
- The latest Wall Street Score change is +0.5 points: IRMD increased 0.5 points because Valuation improved by 3.8 points.
What the numbers mean
Its current valuation score is 4/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 42/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-08-14.
How to research IRMD
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.